Evidence map›Paper›PMID 21060790›Full record

ArticlePloS one2010

Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

José María Sayagués, Celia Fontanillo, María del Mar Abad, María González-González, María Eugenia Sarasquete, Maria del Carmen Chillon, Eva Garcia, Oscar Bengoechea, Emilio Fonseca, Marcos Gonzalez-Diaz and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Prognostic Impact ofCancers · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The role of the cell-cell interactions in cancer progression.Journal of cellular and molecular medicine · 2015
    Review
  10. Article
  11. Article
  12. Metastasis suppressor genes.Histology and histopathology · 2013
    Review
  13. Genomics screens for metastasis genes.Cancer metastasis reviews · 2012
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

José María SayaguésServicio General de Citometría, Departamento de Medicina and Centro de Investigación del Cáncer (IBMCC-CSIC/USAL), Universidad de Salamanca, Salamanca, Spain.
Celia Fontanillo
María del Mar Abad
María González-González
María Eugenia Sarasquete
Maria del Carmen Chillon
Eva Garcia
Oscar Bengoechea
Emilio Fonseca
Marcos Gonzalez-Diaz
Javier De las Rivas
Luís Muñoz-Bellvis
Alberto Orfao
Centro de Investigación del Cáncer · ESComplejo Hospitalario de Salamanca · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor years, the genetics of metastatic colorectal cancer (CRC) have been studied using a variety of techniques. However, most of the approaches employed so far have a relatively limited resolution which hampers detailed characterization of the common recurrent chromosomal breakpoints as well as the identification of small regions carrying genetic changes and the genes involved in them. METHODOLOGY/PRINCIPAL

findingsHere we applied 500K SNP arrays to map the most common chromosomal lesions present at diagnosis in a series of 23 primary tumours from sporadic CRC patients who had developed liver metastasis. Overall our results confirm that the genetic profile of metastatic CRC is defined by imbalanced gains of chromosomes 7, 8q, 11q, 13q, 20q and X together with losses of the 1p, 8p, 17p and 18q chromosome regions. In addition, SNP-array studies allowed the identification of small (<1.3 Mb) and extensive/large (>1.5 Mb) altered DNA sequences, many of which contain cancer genes known to be involved in CRC and the metastatic process. Detailed characterization of the breakpoint regions for the altered chromosomes showed four recurrent breakpoints at chromosomes 1p12, 8p12, 17p11.2 and 20p12.1; interestingly, the most frequently observed recurrent chromosomal breakpoint was localized at 17p11.2 and systematically targeted the FAM27L gene, whose role in CRC deserves further investigations. CONCLUSIONS/SIGNIFICANCE: In summary, in the present study we provide a detailed map of the genetic abnormalities of primary tumours from metastatic CRC patients, which confirm and extend on previous observations as regards the identification of genes potentially involved in development of CRC and the metastatic process.

Indexed as

Chromosome AberrationsPolymorphism, Single NucleotideChromosome MappingColorectal NeoplasmsFemaleHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedNeoplasm MetastasisPolymerase Chain Reaction

Identifiers

PMID21060790
PMCPMC2966422
OpenAlexW2092152677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.